A Study of Refractory Cases of Depressive Illnesses and their Response to Combined Antidepressant Treatment
- 1 March 1974
- journal article
- clinical trial
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 124 (580), 265-272
- https://doi.org/10.1192/bjp.124.3.265
Abstract
Opinions differ on the effectiveness and the risk involved in treating depressive illnesses with combinations of monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants. Some authorities, including the Food and Drug Administration in the United States, the former Witts Committee in this country, and the pharmaceutical firms producing antidepressants, have given serious warnings against combining MAOIs with tricyclic antidepressants. These warnings have been repeated more recently by Beck (1967), Malitz (1966) and Shepherd et al. (1968).Keywords
This publication has 29 references indexed in Scilit:
- Clinical features and treatment of overdosage of monoamine oxidase inhibitors and their interaction with other psychotropic drugsResuscitation, 1972
- Severe hypothermia due to combination of psychotropic drugs and alcohol.BMJ, 1966
- Combining the Antidepressant DrugsBMJ, 1965
- Combining the Antidepressant DrugsBMJ, 1965
- TRANSIENT BRAIN SYNDROME AS A NON-FATAL REACTION TO COMBINED PARGYLINE IMIPRAMINE TREATMENTAmerican Journal of Psychiatry, 1964
- Antidepressant DrugsBMJ, 1964
- COMBINED AMITRIPTYLINE AND PHENELZINE POISONINGAmerican Journal of Psychiatry, 1963
- NON-FATAL REACTION TO IMIPRAMINE-MAO INHIBITOR COMBINATIONAmerican Journal of Psychiatry, 1963
- Possible Synergistic Effects of the New Thymoleptics in Connection with PoisoningJournal of Mental Science, 1961
- Side-effects of PhenelzineBMJ, 1960